Found 509 matching trials
Personalized Neoantigen Cancer Vaccine for Patients With Solid Tumors PHASE1 This clinical trial aims to evaluate the safety, immunogenicity, and prelim...
Show More Location
Vejthani Hospital
Learn More & Join Trial
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis PHASE1 This multi-site, Phase 1/2 clinical trial is an open-label study to identif...
Show More Location
Precision NextGen Oncology
Learn More & Join Trial
QUILT-3.046: NANT Melanoma Vaccine: Combination Immunotherapy in Subjects With Melanoma Who Have Progressed On or After Chemotherapy and PD-1/PD-L1 Therapy PHASE1 This is a phase 1b/2 study to evaluate the safety and efficacy of metronomi...
Show More Location
Multiple Locations
Learn More & Join Trial
Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01) PHASE2 The main goals are after treatment given before surgery, to measure the num...
Show More Location
Southern Cancer Center (SCC) ( Site 8004)
Learn More & Join Trial
A Study to Assess the Safety and Tolerability of Atezolizumab in Combination With Other Immune-Modulating Therapies in Participants With Locally Advanced or Metastatic Solid Tumors PHASE1 This global, multicenter, open-label study will evaluate the safety and tol...
Show More Location
HonorHealth Research Institute - Bisgrove
Learn More & Join Trial
Atezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCC PHASE2 There is an unmet need for patients with intermediate stage hepatocellular ...
Show More Location
Yale New Haven Hospital
Learn More & Join Trial
Nivolumab for the Reversal of Squamous Dysplasia in High Risk Current and Former Smokers PHASE2 The goal of this clinical research study is to determine whether the PD-1 i...
Show More Status
Active Not Recruiting
Location
University of Colorado Anschutz Medical Campus
Learn More & Join Trial
An Investigational Immunotherapy Study of BMS-986310 Administered Alone and in Combination With Nivolumab in Patients With Advanced Solid Tumors PHASE1 The purpose of this study is to determine if BMS-986310 administered in com...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma PHASE2 This study consists of 2 portions. The phase 2 portion is an open-label, si...
Show More Status
Active Not Recruiting
Location
Chan Soon-Shiong Institute for Medicine (CSSIFM)
Learn More & Join Trial
Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors PHASE2 This is a multicenter, multi-arm trial evaluating anti-tumor activity, safe...
Show More Learn More & Join Trial